EcoR1 Capital, LLC

13F Portfolio Filings

Most recent 13F
Q3 2026
Location
San Francisco, CA
CIK
0001587114
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2026 36 2,034,164 ZYME, ANAB, BMY calls, CGON 13F-HR 11/16/2026 000093583626000577
Q2 2026 33 2,016,754 ZYME, ANAB, AKTS, CGON 13F-HR 8/14/2026 000093583626000415
Q1 2026 30 2,340,002 ZYME, ANAB, JAZZ, CNTA 13F-HR 5/15/2026 000093583626000270
Q4 2025 30 2,190,818 ZYME, ANAB, JAZZ, CRNX 13F-HR 2/17/2026 000093583626000101
Q3 2025 30 2,083,869 ZYME, ANAB, QURE, JAZZ 13F-HR 11/14/2025 000093583625000671
Q2 2025 37 1,687,449 ZYME, APLS, JAZZ, ANAB 13F-HR 8/14/2025 000093583625000506
Q1 2025 46 1,683,936 APLS, JAZZ, ZYME, ANAB 13F-HR 5/15/2025 000093583625000338
Q4 2024 59 2,503,454 APLS, ZYME, CRNX, JAZZ 13F-HR 2/14/2025 000093583625000164
Q3 2024 64 2,920,208 APLS, ANAB, CRNX, PRTA 13F-HR 11/14/2024 000093583624000682
Q2 2024 55 3,268,882 APLS, PRTA, SRPT, ANAB 13F-HR 8/14/2024 000093583624000519
Q1 2024 59 3,938,511 APLS, PRTA, ARVN, SRPT 13F-HR 5/15/2024 000093583624000391
Q4 2023 51 3,851,538 APLS, MRTX, PRTA, ARVN 13F-HR 2/14/2024 000093583624000163
Q3 2023 51 2,935,965 PRTA, APLS, MRTX, LKFT 13F-HR 11/14/2023 000093583623000696
Q2 2023 53 3,794,817 PRTA, APLS, SRPT, JNJ calls 13F-HR 8/14/2023 000093583623000570
Q1 2023 58 3,105,402 PRTA, SRPT, APLS, LKFT 13F-HR 5/15/2023 000093583623000412
Q4 2022 66 3,285,597 PRTA, SRPT, APLS, ANAB 13F-HR 2/14/2023 000093583623000229
Q3 2022 76 3,387,071 PRTA, APLS, SRPT, ANAB 13F-HR 11/14/2022 000156761922019766
Q2 2022 80 2,878,118 PRTA, APLS, SRPT, SGEN 13F-HR 8/15/2022 000156761922016025
Q1 2022 87 3,196,181 PRTA, APLS, LKFT, ANAB 13F-HR 5/16/2022 000156761922010677
Q4 2021 76 3,134,114 PRTA, ANAB, RCUS, XNCR 13F-HR 2/14/2022 000156761922003866
Q3 2021 71 2,843,542 PRTA, MORF, ANAB, RCUS RESTATEMENT 11/22/2021 000156761921020941
Q2 2021 72 2,675,754 PRTA, MORF, ANAB, XNCR 13F-HR 8/16/2021 000156761921015658
Q1 2021 71 2,248,383 PRTA, XNCR, MORF, ANAB 13F-HR 5/17/2021 000156761921010348
Q4 2020 66 1,797,231 XNCR, RLAY, STTK, SPRY 13F-HR 2/16/2021 000156761921003800
Q3 2020 50 1,385,947 XNCR, KURA, RLAY, PRTA 13F-HR 11/16/2020 000156761920019716
Q2 2020 49 1,335,693 XNCR, PRTA, ORIC, MORF 13F-HR 8/14/2020 000156761920015276
Q1 2020 51 957,232 PRTA, XNCR, ARVN, DRNA 13F-HR 5/15/2020 000156761920010491
Q4 2019 44 1,054,034 PRTA, XNCR, DRNA, FGEN RESTATEMENT 2/18/2020 000156761920004215
Q3 2019 38 749,426 XNCR, PRTA, ONCE, KURA 13F-HR 11/14/2019 000156761919021573
Q2 2019 39 970,382 KURA, XNCR, ARGX, CRSP 13F-HR 8/14/2019 000156761919017041
Q1 2019 41 923,849 ARGX, KURA, MRTX, CRSP 13F-HR 5/15/2019 000156761919011227
Q4 2018 53 869,349 ARGX, KURA, FGEN, IRWD 13F-HR 2/14/2019 000156761919004400
Q3 2018 50 966,248 FGEN, ASMB, IRWD, ASND 13F-HR 11/14/2018 000156761918006356
Q2 2018 33 914,687 FGEN, IRWD, ASMB, ASND 13F-HR 8/14/2018 000156761918000858
Q1 2018 31 933,286 ASMB, ASND, FGEN, IRWD 13F-HR 5/15/2018 000114036118023901
Q4 2017 30 745,714 ASMB, FGEN, CELGENE CORPORATION calls, IRWD 13F-HR 2/14/2018 000114036118007942
Q3 2017 39 730,261 ASMB, FGEN, IRWD, ASND 13F-HR 11/14/2017 000114036117042799
Q2 2017 36 433,545 ALEXION PHARMACEUTICALS, INC calls, IRWD, ASMB, FGEN 13F-HR 8/14/2017 000114036117032004
Q1 2017 33 361,177 ASMB, IRWD, LKFT, GILEAD SCIENCES INC calls RESTATEMENT 5/19/2017 000114036117021481
Q4 2016 30 288,479 IRWD, LKFT, ASMB, ALXN RESTATEMENT 2/15/2017 000114036117007745
Q4 2016 1 14,684 FGEN NEW HOLDINGS 2/15/2017 000114036117007752
Q3 2016 31 261,623 IRWD, LKFT, BRISTOL MYERS SQUIBB CO calls, ASMB 13F-HR 11/14/2016 000114036116086430
Q2 2016 32 219,175 IRWD, LKFT, RTRX, CYTK 13F-HR 8/15/2016 000114036116076455
Q1 2016 37 247,864 IRWD, FPRX, EPZM, FGEN 13F-HR 5/16/2016 000114036116065705
Q4 2015 31 270,004 FGEN, FPRX, JAZZ PHARMACEUTICALS calls, RTRX 13F-HR 2/16/2016 000114036116052684
Q3 2015 25 216,168 FGEN, ATRA, ARRAY BIOPHARMA INC, RTRX 13F-HR 11/16/2015 000114036115041435
Q2 2015 25 283,588 ATRA, EPZM, ASMB, FGEN 13F-HR 8/14/2015 000114036115031882
Q1 2015 23 267,814 ATRA, EPZM, RCPT, ARRAY BIOPHARMA SR CONV NT 3.000% Due 06/01/2020 RESTATEMENT 5/18/2015 000114036115020512
Q4 2014 22 186,637 KITE, CLVSQ, RCPT, ARRAY BIOPHARMA INC 13F-HR 2/17/2015 000092189515000435
Additional filings from EcoR1 Capital, LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Aktis Oncology, Inc. 13D
AKTS · 01021M104
9.1% 1/20/2026
Event 1/12/2026
Zymeworks Inc. 13D/A
ZYME · 98985Y108
30.7% 11/19/2025
Event 11/16/2025
Galapagos NV 13D/A
LKFT · 36315X101
13.2% 7/28/2025
Event 7/24/2025
iTeos Therapeutics, Inc. 13D
ITOS · 46565G104
27.9% 5/16/2025
Event 5/15/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Prothena Corp Public Ltd Co 13D/A
PRTA · G72800108
0% 5/29/2025
Event 5/27/2025

30 other securities where the latest filing is a 13G, the newest filed 11/16/2026. View all